Sherwin Williams Company is a Cleveland, Ohio based company in the paint and coating manufacturing industry. The company primarily engages in the manufacture, distribution, and sale of paints, coatings, floorcoverings, and related products to professional, industrial, commercial, and retail customers primarily in North and South America and Europe.
| Revenue (TTM) | $24.41B |
| Gross Profit (TTM) | $11.96B |
| EBITDA | $4.71B |
| Operating Margin | 18.10% |
| Return on Equity | 65.10% |
| Return on Assets | 9.52% |
| Revenue/Share (TTM) | $99.41 |
| Book Value | $15.97 |
| Price-to-Book | 20.92 |
| Price-to-Sales (TTM) | 3.32 |
| EV/Revenue | 3.875 |
| EV/EBITDA | 19.98 |
| Quarterly Earnings Growth (YoY) | 14.30% |
| Quarterly Revenue Growth (YoY) | 7.50% |
| Shares Outstanding | $242.76M |
| Float | $224.69M |
| % Insiders | 6.36% |
| % Institutions | 85.15% |
Volatility is currently contracting
Three of the market's most durable dividend-raise histories share an awkward feature for anyone actually trying to live on the checks: the yield is nothing.
Sherwin-Williams (SHW) reported earnings 30 days ago. What's next for the stock?
After reaching an important support level, The Sherwin-Williams Company (SHW) could be a good stock pick from a technical perspective. SHW recently experienced a "golden cross" event, which saw its 50-day simple moving average breaking out above its 200-day simple moving average.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Sherwin-Williams maintains positive volume and share gains despite weak housing demand, supporting my hold rating. SHW's Q2 results showed 7.5% net sales growth and 9.5% adj. EPS growth, but margin risks persist due to raw material cost pressures. September's 8% price increase may not be fully realized in H2, creating timing risks for margin expansion and consensus earnings estimates.
Sherwin-Williams delivered a strong Q2 2026, with double-beat results and 7.6% year-over-year revenue growth to $6.79B. SHW raised full-year 2026 EPS guidance to $11.80–$12.20, reflecting robust pricing power and segment gains, despite integration and margin headwinds from Suvinil. My free cash flow valuation model indicates SHW trades at a 12% discount to fair value, supporting a continued Buy rating.
Sherwin-Williams NYSE: SHW reported high-single-digit consolidated sales growth in the second quarter of 2026, supported by new account wins, share gains and contributions from the Suvinil acquisition, while management said broad demand conditions remained largely unchanged.
Sherwin-Williams tops Q2 earnings and sales estimates as all three segments grow, prompting higher full-year sales and adjusted EPS guidance.
Pre-market futures are mixed at this hour, continuing Monday's trading narrative of rotating out of the tech-heavy Nasdaq and into the blue-chip Dow. The Dow, with strong Q2 results from Coke and elsewhere, is up +413 points at present; the Nasdaq — with microchips once again bring sold — is -270 points.
Interest rates have not moved since December's quarter-point cut to a range of +3.50-3.75%.
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on SHW and any ticker you trade — then tracks every position and per-strategy win rate.
